Red Blood Cell Abnormalities As Seen with May-Grünwald-Giemsa (MGG) Staining

Total Page:16

File Type:pdf, Size:1020Kb

Red Blood Cell Abnormalities As Seen with May-Grünwald-Giemsa (MGG) Staining Red blood cell abnormalities as seen with May-Grünwald-Giemsa (MGG) staining Microcyte Macrocyte Megalocyte Microspherocyte Description Description Description Description Ø < 7 µm, in the smear smaller Large red blood cell, Ø 10 µm, Large red blood cell, oval shape, Small red blood cell, Ø < 6 µm, diameter than the nucleus of a central pallor present no central pallor, always hyper- normal volume, no central small lymphocyte, often chromic pallor Incidence hypochromic Reticulocytes are always Incidence Incidence Incidence macrocytes and reflect the Vitamin B12 or Hereditary spherocytosis Iron deficiency regeneration of erythropoiesis. folate deficiency Hypochromic red blood cell Anulocyte Polychromatic red blood cell Echinocyte Description Description Description Description Central pallor > 1/3 of the cell Pronouncedly hypochromic red Blue-tinged red blood cell with Crenated red cell with evenly surface, often microcytic blood cell with small, peripheral remnants of diffusely distributed distributed and uniformly sized ring of haemoglobin, always RNA, often macrocytic spicules Incidence hypochromic Iron deficiency anaemia Incidence Incidence Incidence Reticulocytosis, unspecific with Artefact. In vitro phenomenon Iron deficiency anaemia severe anaemia and in vivo with acidosis and pH hyperosmolarity Acanthocyte Fragmented red cell Sickle cell Pincered cell Description Description Description Description Membrane spikes of irregular Red blood cell with intact con- Red blood cell with pointed Mushroom-shaped red blood size, unevenly distributed vex and damaged concave side, ends, usually crescent shape, cell, no central pallor pointed ends let the cell appear apparently hyperchromic Incidence as helmet cell Incidence Hepatopathy, Incidence Hereditary spherocytosis, post splenectomy Incidence In peripheral blood only observed band 3 gene defect, Red blood cell fragmentation with homozygous HbS disease, MCHC > 36 g/dL syndrome, findings of ≥ 5 ‰ and sickling in heterozygous disease marked thrombocytopenia can only under oxygen deficiency in point to thrombotic-thrombocy- cell suspension topenic purpura (TTP). This result is a lab emergency and should be communicated by phone. Elliptocyte (ovalocyte) Target cell Stomatocyte Teardrop cell Description Description Description Description Elongated shape with round Round, central Hb concentration Central pallor appears slit-like, Teardrop or pear shape ends, normal central pallor due to dome-shaped hernia of straight or mouth-like Incidence the membrane, followed by an Incidence Incidence Extramedullary haematopoiesis empty zone, then peripheral Hb Hereditary elliptocytosis, Hepatopathy, hereditary with primary myelofibrosis ring two types: haemolytic, non- stomatocytosis haemolytic Incidence Thalassaemia, post splenectomy Basophilic stippling Pappenheimer body Howell-Jolly body Cabot ring Description Description Description Description Numerous small, coarse, blue Dark blue, granular, mostly Round residual nucleus of Round to oval or loop-like, granules, unevenly distributed, irregularly shaped, solitary or purple-brown colour, circular, fine, red-purple inclusion; due to denatured ribosomes multiple inclusions found at cell not refractive, eccentrically point of origin: remnants of (RNA) periphery, Ø max. 1 µm, fre- placed, frequently associated mitotic spindle quently associated with Howell- with acanthocytes, target cells, Incidence Incidence Jolly bodies, biochemically: iron Pappen heimer bodies Unspecific in severe anaemia, Unspecific, with severe protein complexes especially with MDS, AML – Incidence anaemia, e. g. thalassaemia especially in FAB AML-M6, per- Incidence Post splenectomy, severe anae- nicious anaemia, lead poisoning, Post splenectomy mia with intact spleen function, hereditary pyrimidine 5'-nucleo- e. g. pernicious anaemia, MDS tidase deficiency Plasmodium falciparum inclusions Erythroblast Rouleaux Normocytic red blood cell Description Description Description Description Ring type: brown nucleole, ring- Erythroblasts (E) in peripheral Linear arrangement of red Diameter: 7 µm, equals the shaped blue cytoplasm, infested blood of adults are always patho- blood cells simulating a ‘stack diameter of the nucleus of a red blood cell not enlarged, no logical (physiological only in of coins’ small lymphocyte. Colour: granulation or pigmentation, first month of life). In the blood haemoglobin colour (pink – red); Incidence multiple parasites common smear, E are not included in WBC shape: round or oval, central Hypergammaglobulinaemia, differential but counted on top pallor 1/3 of the cell surface; Incidence monoclonal and polyclonal, per 100 WBC. no inclusions. Malaria tropica, > 5 % parasite hyperfibrinogenaemia infestation = severe malaria Incidence Incidence tropica. Plasmodium falciparum Associated with diseases show- Physiological red blood cell must be detected in the blood ing increased erythro- and hae- smear! matopoiesis and in extramedul- lary haematopoiesis Abbreviations: Ø – diameter, RNA – ribonucleic acid, DNA – deoxyribonucleic acid, MDS – myelodysplastic syndrome, AML – acute myeloid leukaemia, BM – bone marrow, Hb – haemoglobin, WBC – white blood cells © Copyright 2015 – Universitätsklinikum Aachen AÖR, Klinik für Hämatologie, Onkologie, Hämostaseologie und Stammzelltransplantation Authors: Reinhild Herwartz, Prof. Dr. med. Roland Fuchs, Medizinische Klinik IV, Uniklinik RWTH Aachen Sysmex Europe GmbH Bornbarch 1, 22848 Norderstedt, Germany · Phone +49 40 52726-0 · Fax +49 40 52726-100 · [email protected] · www.sysmex-europe.com In cooperation with: Universitätsklinikum Aachen Klinik für Hämatologie, Onkologie, Hämostaseologie und Stammzelltransplantation Pauwelsstraße 30, 52074 Aachen, Germany · Phone +49 241 80-0 · [email protected] · www.ukaachen.de You will find your local Sysmex representative’s address under www.sysmex-europe.com/contacts ZE000791.EN.N.10/15.
Recommended publications
  • Modelling of Red Blood Cell Morphological and Deformability Changes During In-Vitro Storage
    applied sciences Article Modelling of Red Blood Cell Morphological and Deformability Changes during In-Vitro Storage Nadeeshani Geekiyanage 1 , Emilie Sauret 1,*, Suvash Saha 2 , Robert Flower 3 and YuanTong Gu 1 1 School of Mechanical, Medical and Process Engineering, Science and Engineering Faculty, Queensland University of Technology (QUT), Brisbane City, QLD 4000, Australia; [email protected] (N.G.); [email protected] (Y.G.) 2 School of Mechanical and Mechatronic Engineering, University of Technology Sydney (UTS), Ultimo, NSW 2007, Australia; [email protected] 3 Research and Development, Australian Red Cross Lifeblood, Kelvin Grove, QLD 4059, Australia; [email protected] * Correspondence: [email protected] Received: 28 February 2020; Accepted: 27 April 2020; Published: 4 May 2020 Featured Application: Red blood cell (RBC) storage lesion is a critical issue facing transfusion treatments, and significant changes in RBC morphology and deformability are observed due to the storage lesion. RBCs require high deformability to sustain in-vivo circulation, and impaired deformability leads to several post-transfusion adverse outcomes. Therefore, improved understanding of the interrelation between the morphological and deformability changes and the quality and viability of the stored RBCs is essential to prevent or reduce the transfusion related adverse outcomes. To support this requisite, the influence on RBC deformability due to several aspects of the storage lesion, namely, the changes in cell morphology, surface area and volume, RBC membrane biomechanics, and cytoskeletal structural integrity are explored numerically in this study. Abstract: Storage lesion is a critical issue facing transfusion treatments, and it adversely affects the quality and viability of stored red blood cells (RBCs).
    [Show full text]
  • Molecular Basis of Spectrin Deficiency in Beta Spectrin Durham. a Deletion
    Molecular basis of spectrin deficiency in beta spectrin Durham. A deletion within beta spectrin adjacent to the ankyrin-binding site precludes spectrin attachment to the membrane in hereditary spherocytosis. H Hassoun, … , S S Chiou, J Palek J Clin Invest. 1995;96(6):2623-2629. https://doi.org/10.1172/JCI118327. Research Article We describe a spectrin variant characterized by a truncated beta chain and associated with hereditary spherocytosis. The clinical phenotype consists of a moderate hemolytic anemia with striking spherocytosis and mild spiculation of the red cells. We describe the biochemical characteristics of this truncated protein which constitutes only 10% of the total beta spectrin present on the membrane, resulting in spectrin deficiency. Analysis of reticulocyte cDNA revealed the deletion of exons 22 and 23. We show, using Southern blot analysis, that this truncation results from a 4.6-kb genomic deletion. To elucidate the basis for the decreased amount of the truncated protein on the membrane and the overall spectrin deficiency, we show that (a) the mutated gene is efficiently transcribed and its mRNA abundant in reticulocytes, (b) the mutant protein is normally synthesized in erythroid progenitor cells, (c) the stability of the mutant protein in the cytoplasm of erythroblasts parallels that of the normal beta spectrin, and (d) the abnormal protein is inefficiently incorporated into the membrane of erythroblasts. We conclude that the truncation within the beta spectrin leads to inefficient incorporation of the mutant protein into the skeleton despite its normal synthesis and stability. We postulate that this misincorporation results from conformational changes of the beta spectrin subunit affecting the binding of the abnormal heterodimer to ankyrin, and we provide evidence […] Find the latest version: https://jci.me/118327/pdf Molecular Basis of Spectrin Deficiency in p8 Spectrin Durham A Deletion within .3 Spectrin Adjacent to the Ankyrin-binding Site Precludes Spectrin Attachment to the Membrane in Hereditary Spherocytosis Hani Hassoun,* John N.
    [Show full text]
  • Erythrocytes: Overview, Morphology, Quantity by AH Rebar Et
    In: A Guide to Hematology in Dogs and Cats, Rebar A.H., MacWilliams P.S., Feldman B.F., Metzger F.L., Pollock R.V.H. and Roche J. (Eds.). Publisher: Teton NewMedia, Jackson WY (www.veterinarywire.com). Internet Publisher: International Veterinary Information Service, Ithaca NY (www.ivis.org), 8-Feb-2005; A3304.0205 Erythrocytes: Overview, Morphology, Quantity A.H. Rebar1, P.S. MacWilliams2, B.F. Feldman 3, F.L. Metzger 4, R.V.H. Pollock 5 and J. Roche 6 1Dept of Veterinary Pathobiology, School of Veterinary Medicine, Purdue University, IN,USA. 2Dept of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, WI, USA. 3Dept of Biomedical Sciences & Pathobiology, VA-MD - Regional College of Veterinary Medicine, Virginia Tech, VA, USA. 4Metzger Animal Hospital,State College,PA, USA. 5Fort Hill Company, Montchanin, DE, USA. 6 Hematology Systems, IDEXX Laboratories, Westbrook, ME, USA. Overview Production Red blood cells (RBC) are produced in the bone marrow. Numbers of circulating RBCs are affected by changes in plasma volume, rate of RBC destruction or loss, splenic contraction, erythropoietin (EPO) secretion, and the rate of bone marrow production. A normal PCV is maintained by an endocrine loop that involves generation and release of erythropoietin (EPO) from the kidney in response to renal hypoxia. Erythropoietin stimulates platelet production as well as red cell production. However, erythropoietin does not stimulate white blood cell (WBC) production. Erythropoiesis and RBC numbers are also affected by hormones from the adrenal cortex, thyroid, ovary, testis, and anterior pituitary. Destruction Red cells have a finite circulating lifespan. In dogs, the average normal red cell circulates approximately 100 days.
    [Show full text]
  • Hereditary Spherocytosis: Clinical Features
    Title Overview: Hereditary Hematological Disorders of red cell shape. Disorders Red cell Enzyme disorders Disorders of Hemoglobin Inherited bleeding disorders- platelet disorders, coagulation factor Anthea Greenway MBBS FRACP FRCPA Visiting Associate deficiencies Division of Pediatric Hematology-Oncology Duke University Health Service Inherited Thrombophilia Hereditary Disorders of red cell Disorders of red cell shape (cytoskeleton): cytoskeleton: • Mutations of 5 proteins connect cytoskeleton of red cell to red cell membrane • Hereditary Spherocytosis- sphere – Spectrin (composed of alpha, beta heterodimers) –Ankyrin • Hereditary Elliptocytosis-ellipse, elongated forms – Pallidin (band 4.2) – Band 4.1 (protein 4.1) • Hereditary Pyropoikilocytosis-bizarre red cell forms – Band 3 protein (the anion exchanger, AE1) – RhAG (the Rh-associated glycoprotein) Normal red blood cell- discoid, with membrane flexibility Hereditary Spherocytosis: Clinical features: • Most common hereditary hemolytic disorder (red cell • Neonatal jaundice- severe (phototherapy), +/- anaemia membrane) • Hemolytic anemia- moderate in 60-75% cases • Mutations of one of 5 genes (chromosome 8) for • Severe hemolytic anaemia in 5% (AR, parents ASx) cytoskeletal proteins, overall effect is spectrin • fatigue, jaundice, dark urine deficiency, severity dependant on spectrin deficiency • SplenomegalSplenomegaly • 200-300:million births, most common in Northern • Chronic complications- growth impairment, gallstones European countries • Often follows clinical course of affected
    [Show full text]
  • Anormal Rbc in Peripheral Blood. [Repaired].Pdf
    1. Acanthocyte 2. Burr-cell 3. Microcyte 1. Basophilic Normoblast 2. Polychromatic Normoblast 3. Pycnotic Normoblast 4. Plasmocyte 5. Eosinophil 6. Promyelocyte 1. Macrocyte 2. Elliptocyte 1. Microcyte 2. Normocyte 1. Polychromatic Erythrocyte 2. Acanthocyte 3. Elliptocyte 1. Polychromatic Normoblast 2. Pycnotic Normoblast 3. Neutrophil Myelocyte 4. Neutrophil Metamyelocyte 1. Schistocyte 2. Microcyte BASOPHILIC ( EARLY ) NORMOBLASTS Basophilic Erythroblast Basophilic Stippling, Blood smear, May-Giemsa stain, (×1000) CABOT'S RINGS Drepanocyte Elliptocyte Erythroblast ERYTHROBLAST in the blood Howell-jolly body Hypo chromic LACRYMOCYTES Leptocyte Malaria, Blood smear, May-Giemsa stain, ×1000 MICROCYTES Orthochromatic erythroblast Pappen heimer Bodies & 1. Schistocyte 2. Elliptocyte 3. Acanthocyte POIKILOCYTOSIS Polychromatic Erythroblast Pro Erytroblast Proerythroblasts Reticulocyte Rouleaux SICKLE CELLS Sickle cell Spherocyte Spherocyte Spherocyte SPHEROCYTES STOMATOCYTES Target Cells Tear Drop Cell, Blood smear, May-Giemsa stain, x1000 Anulocyte 1. Burr-cell 2. Elliptocyte 1. Macrocyte 2. Microcyte 3. Elliptocyte 4. Schistocyte 1. Ovalocyte 2. Lacrymocyte 3. Target cell 1. Polychromatic Erythrocyte 2. Basophilic Stippling 1. Proerythroblast 2. Basophilic Erythroblast 3. Intermediate Erythroblast 4. Late Erythroblast 5. Monocyte 6. Lymphocyte 1. Target-cell 2. Elliptocyte 3. Acanthocyte 4. Stomatocyte 5. Schistocyte 6. Polychromatophilic erythrocyte. 1.Pro erythroblast 2.Basophilic normoblast 3.Polychromatic normoblast 4.Pycnotic normoblast
    [Show full text]
  • Hereditary Spherocytosis
    Hereditary Spherocytosis o RBC band 3 protein testing is a very sensitive and Indications for Ordering specific test for the diagnosis of hereditary Use to confirm diagnosis of hereditary spherocytosis when spherocytosis hemolytic anemia and spherocytes are present Physiology • RBC band 3 protein is a major structural protein of RBCs Test Description o Reduction in the amount of band 3 fluorescence after Test Methodology binding with EMA correlates with spherocytosis • Red blood cell (RBC) surface protein band 3 staining with Genetics eosin-5-maleimide (EMA) analyzed by flow cytometry Clinical Validation Genes: ANK1, EPB42, SLC4A1, SPTA1, SPTB • Validated against the clinical diagnosis of hereditary Inheritance spherocytosis supported by osmotic fragility and/or • Autosomal dominant: 75% molecular testing • Autosomal recessive: 25% Tests to Consider Penetrance: variable Structure/Function Primary Test • Chromosomal location: 17q21.31 RBC Band 3 Protein Reduction in Hereditary Spherocytosis • Provides structure for the red cell cytoskeleton 2008460 • Use to confirm diagnosis of hereditary spherocytosis Test Interpretation when hemolytic anemia and spherocytes are present Sensitivity/Specificity Related Test • Clinical sensitivity: 93% Osmotic Fragility, Erythrocyte 2002257 • Analytical sensitivity/specificity: unknown • Functional testing of RBC sensitivity to osmotic stress Results Disease Overview • Normal o Normal staining of band 3 protein with EMA does not Prevalence: 1/2,000 in northern Europeans suggest hereditary spherocytosis
    [Show full text]
  • Hereditary Spherocytosis (HS)
    Hereditary Spherocytosis (HS) Hereditary spherocytosis (HS) is a medical term for a condition What are the symptoms of HS? which affects the red blood cells. Symptoms of HS are due to 2 processes: hemolysis and anemia. What are red blood cells? When red blood cells break down (hemolysis), they release biliruin Blood contains 3 types of cells: red blood cells (RBC), white blood into the bloodstream, which causes yellowing of the skin (jaundice) cells (WBC), and platelets. Red blood cells are the most common and eyes. Hemolysis causes different problems depending on the type of blood cell, and are responsible for delivering oxygen to all age: parts of the body. • Newborns – may need light therapy or further measures Red blood cells, like white cells and platelets, are continuously made • Children – increasing size of the spleen in the bone marrow. When released into the bloodstream, the average lifespan of a red cell is 120 days. • Teens/adults – gallstones that may require surgery Under the microscope, normal red cells are shaped like discs or If enough red cells are destroyed, the red cell count will be low donuts with the centers partially scooped out. This shape makes (anemia). Symptoms of anemia include looking pale, being tired or them very soft and flexible, so they can easily squeeze through even weak, headaches, poor concentration, and challenges with behavior very small blood vessels. and school. Sometimes there is a problem with the wall of the red cell, and they How is HS treated? change shape to look like spheres or balls. These cells are called ‘spherocytes’.
    [Show full text]
  • Morphological Study of Human Blood for Different Diseases
    Research Article ISSN: 2574 -1241 DOI: 10.26717/BJSTR.2020.30.004893 Morphological Study of Human Blood for Different Diseases Muzafar Shah1*, Haseena1, Kainat1, Noor Shaba1, Sania1, Sadia1, Akhtar Rasool2, Fazal Akbar2 and Muhammad Israr3 1Centre for Animal Sciences & Fisheries, University of Swat, Pakistan 2Centre for Biotechnology and Microbiology, University of Swat, Pakistan 3Department of Forensic Sciences, University of Swat, Pakistan *Corresponding author: Muzafar Shah, Centre for Animal Sciences & Fisheries, University of Swat, Pakistan ARTICLE INFO ABSTRACT Received: August 25, 2020 The aim of our study was the screening of blood cells on the basis of morphology for different diseased with Morphogenetic characters I e. ear lobe attachment, clinodactyly Published: September 07, 2020 and tongue rolling. For this purpose, 318 blood samples were collected randomly. Samples were examined under the compound microscopic by using 100x with standard Citation: Muzafar Shah, Haseena, method. The results show 63 samples were found normal while in 255 samples, different Kainat, Noor Shaba, Sania, Sadia, et al. types of morphological changes were observed which was 68.5%, in which Bite cell 36%, Morphological Study of Human Blood for Elliptocyte 34%, Tear drop cell 30%, Schistocyte 26%, Hypochromic cell 22.5%, Irregular Different Diseases. Biomed J Sci & Tech Res contracted cell 16%, Echinocytes 15.5%, Roleaux 8%, Boat shape 6.5%, Sickle cell 5%, Keratocyte 4% and Acanthocytes 1.5%. During the screening of slides, bite cell, elliptocyte, tear drop cell, schistocytes, hypochromic cell, irregular contracted cells were found 30(1)-2020.Keywords: BJSTR.Human MS.ID.004893. blood; Diseases; frequently while echinocytes, boat shape cell, acanthocytes, sickle cells and keratocytes Morphological; Acanthocytes; Keratocyte were found rarely.
    [Show full text]
  • Complete Blood Count in Primary Care
    Complete Blood Count in Primary Care bpac nz better medicine Editorial Team bpacnz Tony Fraser 10 George Street Professor Murray Tilyard PO Box 6032, Dunedin Clinical Advisory Group phone 03 477 5418 Dr Dave Colquhoun Michele Cray free fax 0800 bpac nz Dr Rosemary Ikram www.bpac.org.nz Dr Peter Jensen Dr Cam Kyle Dr Chris Leathart Dr Lynn McBain Associate Professor Jim Reid Dr David Reith Professor Murray Tilyard Programme Development Team Noni Allison Rachael Clarke Rebecca Didham Terry Ehau Peter Ellison Dr Malcolm Kendall-Smith Dr Anne Marie Tangney Dr Trevor Walker Dr Sharyn Willis Dave Woods Report Development Team Justine Broadley Todd Gillies Lana Johnson Web Gordon Smith Design Michael Crawford Management and Administration Kaye Baldwin Tony Fraser Kyla Letman Professor Murray Tilyard Distribution Zane Lindon Lyn Thomlinson Colleen Witchall All information is intended for use by competent health care professionals and should be utilised in conjunction with © May 2008 pertinent clinical data. Contents Key points/purpose 2 Introduction 2 Background ▪ Haematopoiesis - Cell development 3 ▪ Limitations of reference ranges for the CBC 4 ▪ Borderline abnormal results must be interpreted in clinical context 4 ▪ History and clinical examination 4 White Cells ▪ Neutrophils 5 ▪ Lymphocytes 9 ▪ Monocytes 11 ▪ Basophils 12 ▪ Eosinophils 12 ▪ Platelets 13 Haemoglobin and red cell indices ▪ Low haemoglobin 15 ▪ Microcytic anaemia 15 ▪ Normocytic anaemia 16 ▪ Macrocytic anaemia 17 ▪ High haemoglobin 17 ▪ Other red cell indices 18 Summary Table 19 Glossary 20 This resource is a consensus document, developed with haematology and general practice input. We would like to thank: Dr Liam Fernyhough, Haematologist, Canterbury Health Laboratories Dr Chris Leathart, GP, Christchurch Dr Edward Theakston, Haematologist, Diagnostic Medlab Ltd We would like to acknowledge their advice, expertise and valuable feedback on this document.
    [Show full text]
  • Identifying Peripheral Blood Leukocytes and Erythrocytes in a Patient with Iron Deficiency Anemia
    ADVANCED BLOOD CELL ID: IDENTIFYING PERIPHERAL BLOOD LEUKOCYTES AND ERYTHROCYTES IN A PATIENT WITH IRON DEFICIENCY ANEMIA Educational commentary is provided for participants enrolled in program #259- Advanced Blood Cell Identification. This virtual blood cell identification program includes case studies with more difficult challenges. To view the blood cell images in more detail, click on the sample identification numbers underlined in the paragraphs below. This will open a virtual image of the selected cell and the surrounding fields. If the image opens in the same window as the commentary, saving the commentary PDF and opening it outside your browser will allow you to switch between the commentary and the images more easily. Click on this link for the API ImageViewerTM Instructions. Learning Outcomes After completion of this exercise, participants will be able to: • describe morphologic features of monocytes and lymphocytes, and • identify distinguishing morphologic features in red blood cells associated with iron deficiency anemia. Case Study A 78 year old female patient was seen by her primary care physician due to extreme fatigue and headaches. The CBC results are as follows: WBC=9.3 x 109/L, RBC=4.43 x 1012/L, Hgb=8.7 g/dL, Hct=26.1%, MCV=58.9 fL, MCH=19.6 pg, MCHC=33.3 g/dL, RDW=24.8%, Platelet=425 x 109/L. Educational Commentary The cells annotated for commentary in this advanced testing event were selected from the peripheral blood smear of an elderly woman diagnosed with iron deficiency anemia (IDA). IDA is a common worldwide disorder. It can be caused by lack of adequate dietary iron, the malabsorption of iron, increased need for iron as in pregnancy or infancy and, most often, by bleeding.
    [Show full text]
  • Drinking Water Health Advisory for the Cyanobacterial Toxin Cylindrospermopsin
    United States Office of Water EPA- 820R15101 Environmental Mail Code 4304T June 2015 Protection Agency Drinking Water Health Advisory for the Cyanobacterial Toxin Cylindrospermopsin Drinking Water Health Advisory for the Cyanobacterial Toxin Cylindrospermopsin Prepared by: U.S. Environmental Protection Agency Office of Water (4304T) Health and Ecological Criteria Division Washington, DC 20460 EPA Document Number: 820R15101 Date: June 15, 2015 ACKNOWLEDGMENTS This document was prepared by U.S. EPA Scientists Lesley V. D’Anglada, Dr.P.H. (lead) and Jamie Strong, Ph.D. Health and Ecological Criteria Division, Office of Science and Technology, Office of Water. EPA gratefully acknowledges the valuable contributions from Health Canada’s Water and Air Quality Bureau, in developing the Analytical Methods and Treatment Technologies information included in this document. This Health Advisory was provided for review and comments were received from staff in the following U.S. EPA Program Offices: U.S. EPA Office of Ground Water and Drinking Water U.S. EPA Office of Science and Technology U.S. EPA Office of Research and Development U.S. EPA Office of Children’s Health Protection U.S. EPA Office of General Counsel This Health Advisory was provided for review and comments were received from the following other federal and health agencies: Health Canada U.S. Department of Health and Human Services, Centers for Disease Control and Prevention Drinking Water Health Advisory for Cylindrospermopsin - June 2015 i TABLE OF CONTENTS ACKNOWLEDGMENTS.....................................................................................................................I
    [Show full text]
  • The Influence of Magnetic Fields on Selected Physiological Parameters
    bioRxiv preprint doi: https://doi.org/10.1101/497990; this version posted December 17, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 The Influence of Magnetic Fields on Selected Physiological 2 Parameters of Blood and Tissues in Mice 3 Hani M. Abdelsalama and Mohammed Elywab 4 a Department of Zoology, Faculty of Science, Zagazig University 5 b Department of Biophysics, Faculty of Science, Zagazig University 6 Running title: Effect of magnetic fields on antioxidants and enzymes 7 Manuscript pages: 19, Figures: 7, Tables: 7. 8 *Corresponding author: 9 Hani M. Abdelsalam 10 Department of Zoology, Faculty of Science, Zagazig University Tel.:0020552303252 11 Tel.: +201008051012 E-mail:[email protected] 12 Co-author: 13 Mohammed Elywa E-mail: [email protected] 14 15 Abstract 16 This study aimed to highlight the influence of exposure to different applied magnetic fields (MFs) on 17 SOD, MDA and GSH levels in the liver, LDH and CPK activities in the muscle and γ-aminobutyric acid levels 18 in the brain, as well as some haematological parameters. Adult male albino Swiss mice were divided into 5 19 equal groups (n = 6), the control group (untreated) and four exposure groups that were exposed to MFs of 20, 20 40, 60 and 80 Gauss for 5 min/day for 5 days.: Exposure to MFs induced significant decreases in total GSH 21 levels and SOD activity but a significant increase in MDA levels in the liver.
    [Show full text]